Evofem Biosciences, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary: Evofem Biosciences, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
Evofem Biosciences, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $64K, a 89.5% decline year-over-year.
Evofem Biosciences, Inc. annual Operating Lease, Payments for 2023 was $1.52M, a 42.3% decline from 2022.
Evofem Biosciences, Inc. annual Operating Lease, Payments for 2022 was $2.64M, a 8.78% increase from 2021.
Evofem Biosciences, Inc. annual Operating Lease, Payments for 2021 was $2.43M, a 105% increase from 2020.

Operating Lease, Payments, Annual (USD)

Operating Lease, Payments, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	$1.52M	-$1.12M	-42.3%	Jan 1, 2023	Dec 31, 2023	10-K	2024-03-27
2022	$2.64M	+$213K	+8.78%	Jan 1, 2022	Dec 31, 2022	10-K	2024-03-27
2021	$2.43M	+$1.24M	+105%	Jan 1, 2021	Dec 31, 2021	10-K	2023-04-27
2020	$1.19M	+$351K	+42.1%	Jan 1, 2020	Dec 31, 2020	10-K	2022-03-10
2019	$834K			Jan 1, 2019	Dec 31, 2019	10-K	2021-03-04

Showing 1 to 5 of 5 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.